Physician profile
Larry J Bernstein
NPI 1851380950
$928.87
in general payments reported to CMS, 2019-2025
14 companies · $39.37 in 2025
The $39.37 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $19.98 · 2022: $242 · 2023: $161 · 2024: $234 · 2025: $39.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $280.05 | 2022-2025 | Hyqvia |
| Genentech USA, INC. | $207.81 | 2022-2024 | Xolair |
| Janssen Products, LP | $99.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $64.98 | 2019-2025 | |
| Genzyme Corporation | $53.87 | 2024 | |
| Shire North American Group INC | $44.95 | 2019 | |
| Glaxosmithkline, LLC. | $39.89 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $36.55 | 2023 | Dupixent |
| Janssen Biotech, INC. | $33.94 | 2019 | |
| Dompe US, INC. | $21.77 | 2022 | |
| Viiv Healthcare Company | $17.29 | 2022 | |
| Pfizer INC. | $16.82 | 2023 | |
| Merck Sharp & Dohme LLC | $11.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.